BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 16361561)

  • 1. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
    GAO Y; ZHANG W; ZHAO L; WANG XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):363-7. PubMed ID: 19497203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
    Guan M; Pang CP; Yam HF; Cheung KF; Liu WW; Lu Y
    Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
    Ek ET; Dass CR; Contreras KG; Choong PF
    Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
    Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
    Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
    Yang H; Xu Z; Iuvone PM; Grossniklaus HE
    Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
    Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
    J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
    Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
    Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
    Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model.
    Browne M; Stellmach V; Cornwell M; Chung C; Doll JA; Lee EJ; Jameson JL; Reynolds M; Superina RA; Abramson LP; Crawford SE
    Pediatr Res; 2006 Sep; 60(3):282-7. PubMed ID: 16857775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pigment epithelial derived factor gene on growth of lung cancer cell and neovascularization: experiments with lung cancer cells and chick embryos].
    Chen JF; Zhao W; Zhang JZ; Jiang WG; Zhang LJ
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):485-90. PubMed ID: 19567100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Oncol Rep; 2005 Dec; 14(6):1615-9. PubMed ID: 16273265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
    Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
    Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
    Garcia M; Fernandez-Garcia NI; Rivas V; Carretero M; Escamez MJ; Gonzalez-Martin A; Medrano EE; Volpert O; Jorcano JL; Jimenez B; Larcher F; Del Rio M
    Cancer Res; 2004 Aug; 64(16):5632-42. PubMed ID: 15313901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.